Stockreport

Immuron Partners with CSIRO to produce a new oral therapeutic for clinical evaluation by the US Department of Defense

Immuron Limited - American Depositary Shares  (IMRN) 
US:NASDAQ Investor Relations: immuron.com/investor-centre/business-overview
PDF Key Points Immuron executes a Research Agreement with The Henry M. Jackson Foundation for Advancement of Military Medicine Inc.Immuron executes a Research Agreement w [Read more]